Seamless and efficient transition
We understand the importance of manufacturing material with an impurity profile suitable for IND enabling studies
Our laboratories are equipped with reactors up to 50 L in capacity suitable for production of multi-kilogram scale non-GMP batches of APIs for your preclinical studies, including dose range finding and tox batch requirements. As our synthetic services are fully integrated from discovery chemistry, through the pre-clinical development phase and on to GMP manufacture, a seamless transition into production of the first scale-up batches can be performed. This ensures an efficient supply of material with appropriate control over the impurity profile. Our integrated approach means these batches from early development can offer reliable information regarding the performance of later stage manufacture and materials.